CVR - Coronavirus Vaccines R&D Roadmap

Milestone
1.2.d

Reagent availability

In progress

Promote availability of reagents, such as reference monoclonal antibodies for antigen characterization, necessary for evaluating priority coronaviruses, which include sarbecoviruses and merbecoviruses. 

Progress Highlights

Chen 2025 lists critical reagents for detecting novel coronaviruses, determining putative host range, and investigating therapeutic countermeasures.

CDCreativeDiagnosticsSinoBiological, and R&D Systems have repositories of regents used to characterize different animal and human-derived coronaviruses